Search is Powered by Google
Follow us on:
Follow our health news on Twitter
Follow Our News on Facebook
Personalization
login | register
Women's Health / Gynecology News

September Is Gynecologic Cancer Awareness Month

Main Category: Women's Health / Gynecology
Also Included In: Cancer / Oncology
Article Date: 29 Aug 2009 - 1:00 PDT

email icon email to a friend   printer icon printer friendly   write icon view / write opinions


Current Article Ratings:

Patient / Public:not yet rated

Health Professional:3 stars

3 (1 votes)

Article Opinions: 0 posts

September is Gynecologic Cancer Awareness Month, and The Cancer Institute of New Jersey (CINJ) is making experts available to discuss the risks, treatment and prevention options surrounding the various forms of this disease. Gynecologic cancer is the growth and spread of cancer cells in the cervix, ovaries, uterus, fallopian tubes, vagina and vulva. According to the American Cancer Society, 80,600 new cases of gynecologic cancer will be diagnosed nationwide this year with 27,400 deaths. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

Quick Facts:

Warning signs and symptoms of gynecologic cancers vary depending on type, but may include:

-- Pain or pressure in the pelvic area --Unusual vaginal discharge or bleeding -- Frequent abdominal bloating or swelling -- A sore that does not heal

Risk factors for gynecologic cancers vary depending on type, but may include:

-- Family history

-- Infertility

-- Advanced age

-- Obesity

CINJ experts available for comment include:

Lorna Rodríguez, MD, PhD, chief of gynecologic oncology, CINJ, and professor of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School. Dr. Rodriguez can discuss the importance of annual screenings and the benefits of the cancer vaccination designed to prevent the human papillomavirus (HPV), which the Centers for Disease Control has declared "the main cause" of cervical cancer.

Darlene G. Gibbon, MD, clinical director of gynecologic oncology at CINJ; and assistant professor of Obstetrics, Gynecology and Reproductive Sciences at UMDNJ-Robert Wood Johnson Medical School. Dr. Gibbon's clinical specialty lies in the areas of clinical trial developments; new therapeutics in ovarian, cervical and endometrial cancers; and fertility issues in cancer survivors.

Wilberto Nieves-Neira, MD, gynecologic oncologist, CINJ, and assistant professor of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School. Dr. Nieves-Neira has a long-standing interest in biological therapies, which is directly related to vaccines, specifically the HPV vaccine. He can speak about the HPV vaccination as it pertains to primary healthcare providers and how they address the issue with their patients.

Ami Vaidya, MD, gynecologic oncologist, CINJ, and assistant professor of Obstetrics, Gynecology and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School. Dr. Vaidya can discuss the procedure of minimally invasive cancer surgery and radical trachelectomy, which is a fertility-sparing surgical procedure for early stage cervical cancer.

Source: Cancer Institute of New Jersey




Personalized Homepage Weekly Newsletters Daily News Alerts
Hemophilia Opioid Induced Constipation Pneumococcal Disease ADHD Anxiety Asthma Atrial Fibrillation Autism Cancer Diabetes Lung Cancer Lupus Medicare / Medicaid Obesity and BMI Pancreatic Cancer Stem Cells All 'What Is...' Articles

Ophthalmology Urology
About Us News Licensing Free Website Feeds Free Tools & Content Tell a Friend Accessibility Help / FAQ Article Submission Links Contact Us

add medical news today to your facebook
medical news gadget

Haiti Appeal

Haiti Appeal Image
The severe earthquake that struck Haiti has inflicted damage and devastation on a massive scale. Please donate to the Doctors Without Borders Haiti Appeal.

PLEASE DONATE HERE


These are the most read articles from this news category for the last 6 months:
Top Article Star
Criticism Of Popular Oral Contraceptive Yaz Could Harm Product's Appeal, New York Times Reports
29 Sep 2009
The popular oral contraceptives Yaz and Yasmin have been tainted recently by safety concerns raised by researchers, health advocates and lawyers for plaintiffs who have filed lawsuits against manufacturer Bayer Healthcare, the New York Times reports...


Treating Postpartum Depression image Treating Postpartum Depression

Postpartum depression affects anywhere from 10 to 20 percent of new moms. Thankfully, postpartum depression is an extremely treatable illness...

Talking with Your Doctor image Talking with Your Doctor

Talking with your doctor can sometimes be difficult. Good health care, however, depends on an open dialogue between patients and doctors...

View more videos...